Thomas Finnerty

United States Surgical Corp. engages in the manufacture of wound closure products and surgical devices. It produces tools used in surgery including staplers, sutures, laparoscopic instruments, cardiovascular surgical products and electrosurgical devices. The company was founded in 1964 and is headquartered in North Haven, CT.

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Osteobiologics, Inc. provides medical services. The company develops and manufactures bioabsorbable polymeric scaffolds, films and related instrumentation for the repair and replacement of bone, soft tissue, and articular cartilage. The company was founded by Barbara D. Boyan in 1993 and is headquartered in San Antonio, TX.

Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD.

Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan.

New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Federal Bureau of Investigation provides security and crime-fighting services. It specializes in terrorism, public corruption, cyber crime, and violent crimes. The company was founded in 1908 and is headquartered in Washington, DC.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA.

The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI.

Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN.

Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO.

CellRight Technologies LLC provides medical equipment. It develops osteoinductive and wound care scaffolds. Its products include Matrix OI, MatrixCellect 100 DBM Putty, MatrixCellect 100 DBM Crunch, ConCelltrate, sports medicine, Matrix IQ Dermis, conventional grafts, AmnioWorks, and Matrix OI FlexIT. The company is headquartered in Universay City, TX.

The American Association of Tissue Banks is a premier standard-setting body that promotes the safety and use of donated human tissue. The non-profit company is based in McLean, VA. Marc Pearce has been the CEO of the company since 2020. The organization ensures that safe and efficacious tissue products are available for patients in need. AATB offers professional development and networking opportunities for individuals and organizational collaborations, best practices, and an industry gold-standard accreditation program for institutions.